USCA RIA’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

USCA RIA’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$1.27M	Sell	128,300 -1,700	-1%	-$18K	0.08%	274
2021 Q1	$1.5M	Sell	130,000 -2,272	-2%	-$26.1K	0.1%	254
2020 Q4	$1.28M	Sell	132,272 -11,762	-8%	-$113K	0.09%	211
2020 Q3	$1.3M	Hold	144,034	–	–	0.1%	180
2020 Q2	$1.78M	Sell	144,034 -1,919	-1%	-$21.7K	0.16%	133
2020 Q1	$1.31M	Buy	145,953 +13,850	+10%	+$142K	0.15%	146
2019 Q4	$1.3M	Sell	132,103 -12,640	-9%	-$113K	0.12%	224
2019 Q3	$996K	Buy	144,743 +1,802	+1%	+$13.8K	0.1%	235
2019 Q2	$1.32M	Buy	+142,941	New	+$1.72M	0.13%	198

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

USCA RIA's TEVA Position: Q2 2021 in Review

USCA RIA reduced its Teva Pharmaceutical Industries Limited (TEVA) stake by 1.3% in Q2 2021, selling an estimated $18K and leaving 128,300 shares worth $1.27M. The position accounts for 0.08% of the portfolio, ranked #274.

USCA RIA first reported a position in TEVA in Q2 2019 and has held it in 9 quarters since. The position peaked at $1.78M in Q2 2020. 440 funds tracked by Wall St. Rank hold TEVA as of Q2 2021.

USCA RIA held 128,300 shares of Teva Pharmaceutical Industries Limited worth $1.27M as of Q2 2021.
USCA RIA sold 1,700 Teva Pharmaceutical Industries Limited shares in Q2 2021, an estimated $18K.
Teva Pharmaceutical Industries Limited made up 0.08% of USCA RIA's portfolio in Q2 2021, its #274 holding.
USCA RIA first reported a position in Teva Pharmaceutical Industries Limited in Q2 2019 and has held it in 9 quarters since.
USCA RIA's Teva Pharmaceutical Industries Limited position peaked at $1.78M in Q2 2020.
440 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2021.

Based on USCA RIA's 13F filing for Q2 2021, filed 28 Jul 2021.